New MRC Centre global genomics medicine partnership
13 June 2018
We are delighted to announce that all global partners have signed memoranda of understanding outlining their commitments to this exciting and innovative new initiative to develop a truly International Centre for Genomic Medicine Research in Neuromuscular Diseases to benefit patients in South Africa, Zambia, Brazil, India and Turkey.
Our Mission is to create a transcontinental genomics research and capacity building partnership between the UK and Official Development Assistance Lower and Middle Income Countries (ODA-LMICs) with an initial focus on India, Brazil, South
Africa, Zambia & Turkey. We will discover new disease genes, define the genetic variants in known neuromuscular genes, understand comparative genetic architecture in different populations and explore disease mechanisms. We will dramatically
increase the number of patients with an accurate genetic diagnosis, build "trial ready" cohorts and ultimately improve health outcomes for patients with this unmet health need drawn from a combined population of over 1.5 billion people.
Our Vision is to deliver a mature transcontinental clinical academic partnership led by a new group of outstanding clinical academics graduated from our training programme. They will be an enduring locally sustained legacy of expertise and they will harness genomics to improve the lives and health outcomes of children and adults with serious neuromuscular diseases (NMDs).
Memoranda of Understanding:
International Training Fellow Programme:
support for the international genomics medicine programme from UCL Vice
Provost International and UCL International office: